Zimmer Philipp, Baumann Freerk T, Ebel Janis, Zopf Eva Maria, Bloch Wilhelm, Elter Thomas
Department of Molecular and Cellular Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933 Köln, Germany.
Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, University of Cologne, Kerpener Straße 62, 50937 Köln, Germany.
J Sports Med (Hindawi Publ Corp). 2013;2013:470489. doi: 10.1155/2013/470489. Epub 2013 Mar 21.
Introduction. Resistance training is rarely offered to hemato-oncological patients in the daily clinical routine due to its potential harmful impact on the cardiovascular system and the long periods of thrombocytopenia experienced by these patients. Therefore, it is important to determine a valid assessment to define and control resistance training. In this study, the feasibility of a maximal voluntary contraction (MVC) test was investigated in hemato-oncological patients. This inexpensive assessment may be a practicable alternative to the one repetition maximum test which is currently described as the gold standard. Methods. 29 hemato-oncological patients with platelet counts between 30000/μL and 70000/μL were recruited for this pilot study. Complications like petechial bleedings, muscle convulsion, and pain were assessed using the Brief Pain Inventory before and 48 hours after the MVC test, which was performed unidirectionally for the quadriceps muscle. Results. We did not detect any statistically significant test-related exacerbations or pain development. Discussion. MVC testing seems to be a feasible method to control a resistance training program in hemato-oncological patients. Further studies need to extend their methods and, for example, compare the MVC test with the one repetition maximum test.
引言。在日常临床实践中，很少对血液肿瘤患者进行抗阻训练，因为这可能对其心血管系统产生有害影响，且这些患者会经历长时间的血小板减少。因此，确定一种有效的评估方法来定义和控制抗阻训练非常重要。在本研究中，调查了最大自主收缩（MVC）测试在血液肿瘤患者中的可行性。这种成本低廉的评估方法可能是目前被视为金标准的一次重复最大负荷测试的一种可行替代方法。方法。招募了29名血小板计数在30000/μL至70000/μL之间的血液肿瘤患者参与这项初步研究。在对股四头肌进行单向MVC测试之前和之后48小时，使用简明疼痛量表评估瘀点出血、肌肉抽搐和疼痛等并发症。结果。我们未检测到任何与测试相关的具有统计学意义的病情加重或疼痛加剧情况。讨论。MVC测试似乎是控制血液肿瘤患者抗阻训练计划的一种可行方法。进一步的研究需要扩展其方法，例如，将MVC测试与一次重复最大负荷测试进行比较。
